Abstract:The accurate and precise measurement of endogenous corticosteroids in urine is a powerful tool to understand the biochemical state in several diseases. In this study, a rapid, accurate, and sensitive method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the quantification of 67 endogenous gluco- and mineralo-corticosteroids and progestins has been developed and validated. Sample preparation, chromatographic separation, and mass spectrometric detection were optimized. Urine samples (0.5 mL) were hydrolyzed with β-glucuronidase and the released analytes were extracted by liquid-liquid extraction. The chromatographic separation was performed in 20 min after redisolution of the extract. MS behavior of endogenous corticosteroids was evaluated in order to select the most specific precursor ion ([M+H](+), [M+NH4](+), or [M+H-nH2O](+)) for the detection. MS/MS determination was performed under selected reaction monitoring mode using electrospray ionization in positive mode. The method was shown to be linear (r>0.99) in the range of endogenous concentrations for all studied metabolites. Limits of detection (LOD) below 1 ng mL(-1) were typically obtained for analytes with a 3-oxo-4-ene structure whereas LODs below 15 ng mL(-1) were common for the rest of analytes. Recoveries were higher than 80% and intra-assay precisions below 20%, evaluated at three concentration levels, were found for most steroids. No significant or moderate matrix effect, ranging from 54 to 155%, was observed for most of the analytes. The applicability of the method was confirmed by analyzing 24h urine samples collected from twenty healthy volunteers and comparing the results with previously established normal ranges. The wide coverage of corticosteroid metabolism, together with short analysis time, low sample volume, simple sample preparation, and satisfactory quantitative results make this method useful for clinical purposes.

Determination of CYP3A activity in vivo by the ratio of urinary endogenous 6β-hydroxycortisol to cortisol

Determination the Contents of 6β-hydroxycortisone and Hydrocortisone in Urinary by HPLC

Measurement of ciclosporin in whole blood by HPLC

Diurnal variation of 6beta-hydroxycortisol in cardiac patients

Study on Activity of CYP3A of Female Students in Shanghai

Distribution of CYP3A Activities of Children from 6 Through 12 Years Old in Shanghai

Distribution of CYP3A Activity of Students in Junior Middle School in Shanghai

Distribution of Cytochrome P450 3A Activity in School-Age Children in Shanghai

[Determination of Cortisol in Plasma and 24-Hour Urine of Patients with Central Serous Chorioretinopathy].

Study on CYP3A Activity of School Boys by HPLC

Distribution of Human CYP3A Activity in 544 Children at School Age in Shanghai

Determination method of CYP3A activity and individualization dosage regimen of etoposide

LC-HRMS and GC-MS Profiling of Urine Free Cortisol, Cortisone, 6Β-, and 18-Hydroxycortisol for the Evaluation of Glucocorticoid and Mineralocorticoid Disorders

Validation of a LC-MS/MS method for establishing reference intervals and assessing diagnostic performance of urinary free cortisol and cortisone

Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis

Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry

DETERMINATION OF CYP2D6 ACTIVITY BY CAPILLARY GAS CHROMATOGRAPHY AND ITS APPLICATION IN METABOLIC PHENOTYPING

Effects of Sex and Development in Puberty on CYP3A Activity

Simultaneous Determination of Cortisone and Cortisol in Serum by Hplc-Dad and Application for Pharmacokinetics

Influence of CYP3A5 and MDR1 Genetic Polymorphisms on Urinary 6β‐hydroxycortisol/cortisol Ratio after Grapefruit Juice Intake in Healthy Chinese

Influence of Thyroid Hormone on Cortisol Biosynthesis. A Gaschromatographic Analysis